Evidence map›Paper›PMID 31941708›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2020

Medical Financial Hardship Intensity and Financial Sacrifice Associated with Cancer in the United States.

Xuesong Han, Jingxuan Zhao, Zhiyuan Zheng, Janet S de Moor, Katherine S Virgo, K Robin Yabroff

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Financial toxicity among breast cancer survivors receiving care during the pandemic.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Exploring the Impact of Financial Toxicity in COPD: A Qualitative Study.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Association of cancer with racial disparities in financial health: a national cohort study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Observational
  14. Enduring Economic Effects of a Cancer Diagnosis in Adolescence and Young Adulthood.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Article
  15. Quantifying and addressing self-defined needs in cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Financial toxicity amongst cancer patients and survivors: a comparative study of the United Kingdom and United States.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xuesong HanSurveillance and Health Services Research Program, American Cancer Society, Atlanta, Georgia. xuesong.han@cancer.org.
Jingxuan ZhaoSurveillance and Health Services Research Program, American Cancer Society, Atlanta, Georgia.
Zhiyuan ZhengSurveillance and Health Services Research Program, American Cancer Society, Atlanta, Georgia.
Janet S de MoorDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
Katherine S VirgoDepartment of Health Policy and Management, Emory University, Atlanta, Georgia.ORCID 0000-0002-2069-0585
K Robin YabroffSurveillance and Health Services Research Program, American Cancer Society, Atlanta, Georgia.ORCID 0000-0003-0644-5572

Funding

Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

backgroundWith rising costs of cancer care, this study aims to estimate the prevalence of, and factors associated with, medical financial hardship intensity and financial sacrifices due to cancer in the United States.

methodsWe identified 963 cancer survivors from the 2016 Medical Expenditures Panel Survey - Experiences with Cancer. Medical financial hardship due to cancer was measured in material (e.g., filed for bankruptcy), psychological (e.g., worry about paying bills and finances), and behavioral (e.g., delaying or forgoing care due to cost) domains. Nonmedical financial sacrifices included changes in spending and use of savings. Multivariable logistic models were used to identify characteristics associated with hardship intensity and sacrifices stratified by age group (18-64 or 65+ years).

resultsAmong cancer survivors ages 18 to 64 years, 53.6%, 28.4%, and 11.4% reported at least one, two, or all three domains of hardship, respectively. Among survivors ages 65+ years, corresponding percentages were 42.0%, 12.7%, and 4.0%, respectively. Moreover, financial sacrifices due to cancer were more common in survivors ages 18 to 64 years (54.2%) than in survivors 65+ years (38.4%;

conclusionsMedical financial hardship and financial sacrifices are substantial among cancer survivors in the United States, particularly for younger survivors. IMPACT: Efforts to mitigate financial hardship for cancer survivors are warranted, especially for those at high risk.

Indexed as

Cost of IllnessAdolescentAdultAgedAge FactorsCancer SurvivorsFemaleFinancial StressHealth ExpendituresHumansMaleMiddle AgedNeoplasmsUnited StatesYoung Adult

Identifiers

PMID31941708
PMCPMC7007367

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.